Preclinical evaluation of destruxin B as a novel Wnt signaling target suppressing proliferation and metastasis of colorectal cancer using non-invasive bioluminescence imaging

文化大學機構典藏 CCUR > 環境規劃暨生物資源學院 > 農學院 > 園藝暨生物技術學系 > 期刊論文 > Item 987654321/24239

jsp.display-item.identifier=請使用永久網址來引用或連結此文件: https://irlib.pccu.edu.tw/handle/987654321/24239

题名:	Preclinical evaluation of destruxin B as a novel Wnt signaling target suppressing proliferation and metastasis of colorectal cancer using non-invasive bioluminescence imaging
作者:	Yeh, CT (Yeh, Chi-Tai) Rao, YK (Rao, Yerra Koteswara) Ye, M (Ye, Min) Wu, WS (Wu, Wen-Shi) Chang, TC (Chang, Tung-Chen) Wang, LS (Wang, Liang-Shun) Wu, CH (Wu, Chih-Hsiung) Wu, ATH (Wu, Alexander T.H.) Tzeng, YM (Tzeng, Yew-Min)
贡献者:	Dept Hort & Biotechnol
关键词:	Destruxin B Human colorectal carcinoma Apoptosis Migration and invasion Wnt-signaling pathway In vivo bioluminescence
日期:	2012-05
上传时间:	2013-02-21 10:56:50 (UTC+8)
摘要:	In continuation to our studies toward the identification of direct anti-cancer targets, here we showed that destruxin B (DB) from Metarhizium anisopliae suppressed the proliferation and induced cell cycle arrest in human colorectal cancer (CRC) HT29, SW480 and HCT116 cells. Additionally, DB induced apoptosis in HT29 cells by decreased expression level of anti-apoptotic proteins Bcl-2 and Bcl-xL while increased proapoptotic Bax. On the other hand, DB attenuated Wnt-signaling by downregulation of beta-catenin, Tcf4 and beta-catenin/Tcf4 transcriptional activity, concomitantly with decreased expression of beta-catenin target genes cyclin D1, c-myc and survivin. Furthermore, DB affected the migratory and invasive ability of HT29 cells through suppressed MMPs-2 and -9 enzymatic activities. We also found that DB targeted the MAPK and/or PI3K/Akt pathway by reduced expression of Akt, IKK-alpha, JNK, NF-kappa B, c-Jun and c-Fos while increased that of I kappa B alpha. Finally, we demonstrated that DB inhibited tumorigenesis in HT29 xenograft mice using non-invasive bioluminescence technique. Consistently, tumor samples from DB-treated mice demonstrated suppressed expression of beta-catenin, cyclin D1, survivin, and endothelial marker CD31 while increased caspase-3 expression. Collectively, our data supports DB as an inhibitor of Wnt/beta-catenin/Tcf signaling pathway that may be beneficial in the CRC management. (C) 2012 Elsevier Inc. All rights reserved.
關聯:	TOXICOLOGY AND APPLIED PHARMACOLOGY 卷: 261 期: 1 頁數: 31-41
显示于类别:	[園藝暨生物技術學系] 期刊論文

文件中的档案:

档案	描述	大小	格式	浏览次数
index.html		0Kb	HTML	436	检视/开启

检视Licence

在CCUR中所有的数据项都受到原著作权保护.

数据加载中.....